|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of products sold | |||||
| Gross profit | |||||
| Selling, general and administrative expense | |||||
| Restructuring costs, net | |||||
| Impairment of goodwill, intangibles and other assets | |||||
| Operating income (loss) | |||||
| Non-operating expenses: | |||||
| Interest expense, net | |||||
| Loss on extinguishment and modification of debt | |||||
| Other expense, net | |||||
| Loss before income taxes | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Other comprehensive loss, net of tax | |||||
| Foreign currency translation adjustments | |||||
| Unrecognized pension and postretirement costs | |||||
| Derivative financial instruments | |||||
| Total other comprehensive income (loss), net of tax | |||||
| Comprehensive income (loss) | |||||
| Total comprehensive income attributable to noncontrolling interests | |||||
| Foreign currency translation adjustments | |||||
| Unrecognized pension and postretirement costs | |||||
| Derivative financial instruments | |||||
| Total other comprehensive income (loss), net of tax | |||||
| Total comprehensive loss | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Loss per share: | |||||
| Basic (in USD per share) | |||||
| Diluted (in USD per share) | |||||
Loading...